Sexual behavior, condom use, and human papillomavirus: Pooled analysis of the IARC human papillomavirus prevalence surveys

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 2, 2006, Pages 326-333

  Vaccarella, Salvatore ^a   Franceschi, Silvia ^a   Herrero, Rolando ^b   Muñoz, Nubia ^c   Snijders, Peter J F ^d   Clifford, Gary M ^a   Smith, Jennifer S ^e   Lazcano Ponce, Eduardo ^f   Sukvirach, Sukhon ^g   Shin, Hai Rim ^h   De Sanjosé, Silvia ⁱ   Molano, Monica ^c   Matos, Elena ^j   Ferreccio, Catterina ^k   Anh, Pham Thi Hoang ^l,n   Thomas, Jaiye O ^m   Meijer, Chris J L M ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c Instituto Nacional de Cancerología   (Colombia)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e IL   (United States)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^g NATIONAL CANCER INSTITUTE   (Thailand)

^h National Cancer Center   (South Korea)

ⁱ CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^j UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^k PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^l National Cancer Institute   (Viet Nam)

^m UNIVERSITY OF IBADAN   (Nigeria)

ⁿ PATH Canada Vietnam Office   (Viet Nam)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONDOM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VIRUS DIAGNOSIS; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CONDOMS; FEMALE; HEALTH SURVEYS; HERPESVIRUS 2, HUMAN; HUMANS; INTERNATIONAL AGENCIES; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 33644747112     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0577     Document Type: Article

References (43)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
2. IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomavirus. Lyon: IARC; 1995.
3. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-63.
4. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starring sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6.
5. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-64.
6. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 83:1565-72.
7. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26.
8. Muñoz N, Mendez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077-87.
9. Richardson H, Franco E, Pintos J, Bergeron J, Arella M, Tellier P. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sex Transm Dis 2000;27:79-86.
10. Rousseau MC, Franco EL, Villa LL, et al. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000;9:469-76.
11. Silins I, Kallings I, Dillner J. Correlates of the spread of human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2000;9:953-9.
12. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29:725-35.
13. Anh PTH, Hieu NT, Herrero R, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213-20.
14. Sukvirach S, Smith JS, Tunsakul S, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246-56.
15. Shin HR, Lee DH, Herrero R, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413-21.
16. Lazcano-Ponce E, Herrero R, Muñoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
17. Matos E, Loria D, Amestoy GM, et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003;30:593-9.
18. Ferreccio C, Prado RB, Luzoro AV, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004;13:2271-6.
19. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
20. Thomas JO, Herrero R, Omigbodun AA, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
21. de Sanjosé S, Almirall R, Lloveras B, et al. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.
22. Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJF, Meijer CJLM, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33:901-5.
23. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJF. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
24. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
25. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
26. Ribes JA, Hayes M, Smith A, Winters JL, Baker DJ. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics. J Clin Microbiol 2001;39:3740-2.
27. Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM, Jr. Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis 1995;22:236-43.
28. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991;10:1025-35.
29. Plummer M. Improved estimates of floating absolute risk. Stat Med 2004;23:93-104.
30. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757-65.
31. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
32. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior. II. Accuracy of self-reports. Ann Behav Med 2003;26:104-23.
33. Muñoz N, Castellsagué X, Bosch FX, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996;88:1068-75.
34. Bousarghin L, Touze A, Sizaret PY, Coursaget P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol 2003;77:3846-50.
35. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
36. Kjaer SK, van den Brule AJ, Bock JE, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
37. Brinton LA, Hamman RF, Huggins GR, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987;79:23-30.
38. Cuzick J, Singer A, De Stavola BL, Chomet J. Case-control study of risk factors for cervical intraepithelial neoplasia in young women. Eur J Cancer 1990;26:684-90.
39. Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002;185:28-35.
40. Green J, Berrington de Gonzalez A, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003;89:2078-86.
41. Molano M, van den Brule A, Plummer M, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003;158:486-94.
42. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004;31:601-7.
43. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004;82:454-61.